Early Experience with the Paul Glaucoma Implant in Childhood Glaucoma: A Case Series

Abdelrahman M Elhusseiny1,2, Mohamed M Khodeiry3,4, Richard K Lee4

  • 1Department of Ophthalmology, Harvey and Bernice Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Insights

The novel Paul glaucoma implant (PGI) effectively lowers intraocular pressure in children with refractory glaucoma. This early study found PGI to be safe and efficient in pediatric cases.

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Pediatric Ophthalmology

Background:

  • The Paul glaucoma implant (PGI) is a novel, non-valved glaucoma drainage device (GDD) designed to reduce intraocular pressure (IOP) with a theoretically lower risk of complications.
  • Limited data exists on PGI use in adult glaucoma, and its application in pediatric glaucoma remains undocumented.

Purpose of the Study:

  • To present the initial clinical experience with the Paul glaucoma implant (PGI) in managing refractory childhood glaucoma.
  • To evaluate the safety and efficacy of PGI in pediatric glaucoma patients.

Main Methods:

  • A retrospective, single-surgeon case series was conducted at a single tertiary center.
  • The study included three eyes from three patients diagnosed with childhood glaucoma.

Main Results:

  • Over a nine-month follow-up period, all patients demonstrated significantly reduced postoperative IOP and required fewer glaucoma medications compared to preoperative levels.
  • No patients experienced postoperative complications, including hypotony, choroidal detachment, endophthalmitis, or corneal decompensation.

Conclusions:

  • The Paul glaucoma implant (PGI) appears to be an effective and safe surgical option for refractory childhood glaucoma.
  • Further research with larger cohorts and extended follow-up is warranted to validate these preliminary findings.
Abstract

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
623
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
481
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
574